Truist Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Sell |
|
|||||
|
2025
Q1 | $347K | Sell |
|
|||||
|
2024
Q4 | $450K | Sell |
|
|||||
|
2024
Q3 | $683K | Buy |
|
|||||
|
2024
Q2 | $402K | Sell |
|
|||||
|
2024
Q1 | $472K | Sell |
|
|||||
|
2023
Q4 | $561K | Sell |
|
|||||
|
2023
Q3 | $678K | Sell |
|
|||||
|
2023
Q2 | $905K | Buy |
|
|||||
|
2023
Q1 | $597K | Buy |
|
|||||
|
2022
Q4 | $659K | Buy |
|
|||||
|
2022
Q3 | $477K | Buy |
|
|||||
|
2022
Q2 | $456K | Sell |
|
|||||
|
2022
Q1 | $559K | Buy |
|
|||||
|
2021
Q4 | $537K | Buy |
|
|||||
|
2021
Q3 | $575K | Buy |
|
|||||
|
2021
Q2 | $590K | Sell |
|
|||||
|
2021
Q1 | $741K | Buy |
|
|||||
|
2020
Q4 | $846K | Buy |
|
|||||
|
2020
Q3 | $432K | Buy |
|
|||||
|
2020
Q2 | $360K | Buy |
|